CADILA HEALTHCARE LTD. - 532321 - Investor Conference
Participation in Motilal Oswal Investor Conference31-08-2020
CADILA HEALTHCARE LTD. - 532321 - Investor Conference
Participation in Motilal Oswal Investor ConferenceCADILA HEALTHCARE LTD. - 532321 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Cadila Healthcare Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click hereCADILA HEALTHCARE LTD. - 532321 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Disclosure of voting pattern under regulation 44(3) of the SEBI Listing Regulations.CADILA HEALTHCARE LTD. - 532321 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer''s Report on the voting results for the 25th AGM along with the announcement of results by the Chairman.Zydus Wellness plans 1,100-cr fund-raising
The board of Zydus Healthcare, an arm of Zydus Cadila group, has cleared the proposal to raise close to 1,100 crore through a mix of options includiCADILA HEALTHCARE LTD. - 532321 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 25th AGMCADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation
Revised Investor PresentationCADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor PresentationCADILA HEALTHCARE LTD. - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share CertificateCoronavirus vaccine: Oxford vaccine to be India's first shot; Australia to offer doses for free
Coronavirus vaccine news update: Oxford vaccine could be the first antidote to be released in India. Bharat Biotech's COVAXIN and Zydus Cadila's ZyCoV-D are in initial stages of trials